Funding in the biotech/medtech/diagnostics industries have experienced significant volatility over the last couple years. Despite recent hardships in life sciences, people are optimistic about the future.
Join us for a discussion with capital markets partner Amanda Rose and M&A partner Victoria Lupu from Fenwick on the different paths to liquidity, from public offerings to strategic acquisitions, and how to best navigate current and future market pressures.
This series is for anyone interested in startups and entrepreneurship, including students, researchers, and entrepreneurs. Bring your questions!
Sessions are NOT recorded.